教授，博士，博士生导师，河南省教育厅学术技术带头人。兼任中国教育管理学会常务委员会委员，河南省药学会药物制剂专业委员会委员，国际控释协会中国分会会员，中国微米纳米技术学会高级会员，中国生物物理学会会员，河南省药品评审专家，"Adv. Mater."等期刊审稿人。2006年至2007年，北京大学药学院访问学者；2011年至2012年，美国俄亥俄州立大学药学院，美国NSF 纳米科学和工程中心研究学者，参与NIH项目研究；2018年8月至2019年2月，美国堪萨斯大学医学中心，访问学者。主持国家自然科学基金面上项目一项。参与完成国家自然科学基金面上和青年项目3项。主持完成了河南省科技攻关项目，河南省教改项目及青年骨干教师等项目。已完成6个新药的一期临床试验。在国内外刊物"Adv Funct Mater"、" Nanoscale "、 "J Control Release"、" Eur J Pharm Biopharm "等以第一作者或通讯作者发表学术论文40余篇；申请国家发明专利5项。获得省级科技进步奖2项；厅局级奖4项；出版教材3部。获省自然科学优秀学术论文一等奖和二等奖5 项；2013年度河南省信息技术教育优秀成果二等奖和三等奖各1项。培养博士生、硕士生24人。
联系方式：13598040837
邮箱：huyr@zzu.edu.cn.
工作与教育经历：
2019/3-至今, 郑州大学, 药学院, 教授
2018/8-2019/2，美国堪萨斯大学医学中心，访问学者
2014/1-2018/7，郑州大学，药学院，教授
2012/1-2014/1，郑州大学，药学院，副教授
2011/1-2012/1，美国俄亥俄州立大学，药学院和美国NSF纳米科学和工程中心，副教授
2006/9-2007/8，北京大学，药学院，副教授
2006/9–2010/7， 郑州大学， 病理学和病理生理学， 博士
2000/9–2003/7， 郑州大学， 药理学， 硕士
1988/9–1992/7， 沈阳药科大学， 药物制剂， 学士
社会兼职：
● 河南省药品评审专家
● 中国教育管理学会常务委员会委员
• 河南省药学会药物制剂专业委员会委员
荣誉称号及奖励：
• 2014年度河南省教育厅学术技术带头人
专著与教材：
主持或参加研究项目：
1. 河南省高等学校重点科研项目计划，18A350003，基于外泌体捕获检测系统的构建及其用于肝癌早期诊断的研究，2018/01-2019/12，5万元，已结题，主持
2. 国家自然科学基金面上项目，81272563，microRNA 干扰联合热疗的金纳米笼肝肿瘤靶向控释治疗和成像研究，2013/01-2016/12，65万元，已结题，主持
3. 国家自然科学基金青年科学基金项目，81101684，多机制治疗皮下肿瘤的具有光敏性的纳米粒水凝胶基础研究，2012/01-2014/12，22万元，已结题，参与
4. 国家自然科学基金面上项目，30772543，新型免疫脂质体介导双基因对实验性人肝癌的特异靶向性研究，2008/01-2010/12，29万元，已结题，参与
5. 国家自然科学基金青年科学基金项目，20502023，多组分反应研究-合成三尖杉碱骨架，2006/01-2008/12，26万元，已结题，参与
国家发明专利：
1. 胡玉荣，黄胜楠，邱晓静，鲍士金，王静，闫莉娟，李焕杰，王卫萍，刘莹，张宁霞，牛振喜，一种靶向金银合金纳米笼的药物递送系统的制备方法及应用，授权，2019.03.06，CN201510558557.1
2. 胡玉荣，李春明，李焕杰，闫莉娟，黄胜楠，鲍士金，邱晓静，牛振喜，张宁霞，刘莹，王卫萍，一种以金纳米笼为载体的复合靶向药物控释系统的制备方法及应用，授权，2018.07.27，CN201510558558.6
3. 胡玉荣，牛振喜，陈杰，张宁霞，姚兴，段少峰，黄胜楠，张军霞，王卫萍，刘莹，吉梦飞，李慧丽，李元敏，袁金秀，徐鑫，王娟，赵建辉，一种两亲性聚合物的制备方法及其应用，授权，2018.05.01，ZL201610868545.3
4. 胡玉荣，吉梦飞，李慧丽，袁金秀，段少峰，徐鑫，黄胜楠，一种基于肿瘤早期诊断的试剂盒、方法及应用，公开，2018.04.10，CN201711403483.X
5. 胡玉荣，赵宏巧，刘洋，郭新红，耿鑫，王静，李春明，黄佳妮，一种醋氯芬酸-PLGA 微球水凝胶的制备方法，公开，2013.04.10，CN201310046205.9
学术论文：
1. Huili Li#, Huanjie Li#, Wei Yu, Shengnan Huang, Ying Liu, Ningxia Zhang, Jinxiu Yuan, Xin Xu, Shaofeng Duan*, Yurong Hu*. PEGylated hyluronidase/NIR induced durg controlled release system for synergetic chemo-photothermal therapy of hepatocellular carcinoma. European journal of pharmaceutical sciences: official journal of European Federation for Pharmaceutical Sciences,2019, 133:127–136(二区)
2. Yuanmin Li, Linlin Wang, Zhihui Dong, Shiying Wang, Lili Qi, Kenka Cho, Zhou Zhang, Na Li, Yurong Hu*, Baohong Jiang*.Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism.Phytomedicine, 2019, 57: 255-261(一区)
3. Mengfei Ji#, Xiaojing Qiu#, Lin Hou, shengnan Huang, Yuanmin Li, Yang Liu, Shaofeng Duan, Yurong Hu*. Constructionand application of a liver cancer-targeting drug delivery system based on core–shell gold nanocages. International journal of nanomedicne, 2018, 13: 1773-1789(一区)
4. Lijuan Yan#, Xinhong Guo#, Weiping Wang, Yurong Hu*,Shaofeng Duan*, Ying Liu, Zhi Sun, Shengnan Huang, Huili Li. Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs/PEI/miRNA/HA Nanocomplexes. European journal of pharmaceutical sciences, 2018, 18 (1) : 1-8(三区)
5. Weiping Wang#, Shengnan Huang#, Jinxiu Yuan, Xin Xu, Huili Li, Zhanwei Lv, Wei Yu, Shaofeng Duan* ,Yurong Hu*.Reverse Multidrug Resistance in Human HepG2/ADR by Anti-miR-21 Combined with Hyperthermia Mediated by Functionalized Gold Nanocages.Molecular Pharmaceutics, 2018, 15: 3767-3776(二区)
6. Lin Hou*, Yazhen Zheng, Yongchao Wang, Yurong Hu, Jinjin Shi, Qi Liu, Huijuan Zhang, and Zhenzhong Zhang*.Self-Regulated Carboxyphenylboronic Acid-Modifified Mesoporous Silica Nanoparticles with “Touch Switch” Releasing Property for Insulin Delivery. ACS Applied Materials & Interfaces, 2018.6.12(一区)
7. Shengnan Huang#, Ying Liu#, Xin Xu, Mengfei Ji, Yuanmin Li, Chengjun Song, Shaofeng Duan, Yurong Hu*. Triple therapy of hepatocellular carcinoma with microRNA-122 and doxorubicin co-loaded functionalized gold nanocages.Journal of Materials Chemistry B, 2018, 6: 2217-2229(一区)
8. Shijin Bao, Shengnan Huang, Weiping Wang, Ying Liu, Mengfei Ji, Huili Li, Ningxia Zhang, Shaofeng Duan, Zhengzhong Zhang, Yurong Hu*. Gene drug delivery in vitro and vivo of different size functionalized gold nanocages. Nanomedicine: Nanotechnology, Biology and Medicine,2018.14:1797(二区)
9. Xiaojing Qiu, Mengfei Ji, Yuanmin Li, Shengnan Huang, Yurong Hu*. Construction and application of a liver cancer-targeting drug delivery systembased on core-shell gold nanocages. Nanomedicine: Nanotechnology, Biology and Medicine,2018, 13: 1773-1789（二区)
10. Huanjie Li, Huili Li, Shengnan Huang, Ying Liu, Ningxia Zhang，Yurong Hu*. In vitro and in vivo quantitative evaluation of the long-circulation multistimuli responsive gold nanocages. Nanomedicine: Nanotechnology, Biology and Medicine,2018,14(5)1796-1797(二区)
11. Shijin Bao, Shengnan Huang, Ying Liu, Yurong Hu*, Weiping Wang. Mengfei Ji, Huili Li, Ning Xia Zhang, Chengzhi Song, Shaofeng Duan. Gold nanocages with dual modality for image-guided therapeutics. Nanoscale, 2017, 9, 7284-7296(一区)
12. Shengnan Huang, Chunming Li, Mengfei Ji, Weiping Wang, Ying Liu, Lijuan Yan，Shaofeng Duan, Yurong Hu*.A54 peptide-mediatedfunctionalized gold nanocages for targeted delivery of doxorubicin incombination of chemotherapy and photothermal therapy against hepatocellularcarcinoma. Nanomedicine: Nanotechnology, Biology and Medicine,2017, 12: 5163-5176(二区)
13. XinHong Guo, CaiPing Chen, Xin Liu, PanPan Hou, XiaoNan Guo, Fang Ding, ZhiHao Wang, YuRong Hu, Zhi Li*, ZhenZhong Zhang*. High oral bioavailability of 2-methoxyestradiol in PEG-PLGA micelles-microspheres for cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 2017, 117: 116–122(二区)
14. Lihua Zuo#, Zhi Su#)(*, Yurong Hu, Ya Sun, Wenhua Xue, Lin Zhou, Jun Zhang, Xiaoyue Bao, Zhenfeng Zhu, Guanglu Suo, Xiaojian Zhang*. Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis. Journal of Pharmaceutical and Biomedical Analysis, 2017, 137: 220–228(三区)
15. Shengnan Huang, Shaofeng Duan, Jing Wang, Shijin Bao, XiaojingQiu, Chunming Li, Ying Liu, Lijuan Yan, Zhenzhong Zhang, Yurong Hu*. Folic-Acid-Mediated Functionalized Gold Nanocages for Targeted Delivery of Anti-miR-181binCombination of Gene Therapy and Photothermal Therapy against HepatocellularCarcinoma. Advqnced Functional Materials, 2016, 26(15)2532-2544(一区)
16. Yurong Hu, Yingying Shen, Baofang Ji, Shasha Yin, Xueling Ren, Tingting Chen, Yue Ma, Zhenzhong Zhang, Yun Zhang. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes. European Journal of Pharmaceutics and Biopharmaceutics, 2011,78(3):320-325(二区)
17. Yurong Hu, Yingying Shen, Baofang Ji, Lei Wang, Zhenzhong Zhang, YunZhang. Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERT.European Journal of Pharmaceutical Sciences, 2011, 42(4):387-391(三区)
18. Yurong Hu, Xueling Ren, Hui Wang, Yue Ma, Lei Wang, Yingying Shen, Oka. Kazuhiro, Zhenzhong Zhang*, Yun Zhang. Liver-specific expression of an exogenous gene controlled by human apolipoprotein A-I promoter. International Journal of Pharmaceutics, 2010,398(1-2):161-164(三区)
19. Yurong Hu, Kun Li, Lei Wang, Shasha Yin, Zhenzhong Zhang, Yun Zhang. Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy. Journal of Controlled Release, 2010,144(1):75-81(一区)
